Rein Therapeutics, Inc. - Common Stock, $0.001 par value (RNTX)

Historical Holders from Q4 2022 to Q3 2025

Symbol
RNTX on Nasdaq
CUSIP
00887A204
Type / Class
Equity / Common Stock, $0.001 par value
Shares outstanding
23.6M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
8.49M
Holdings value
$9.76M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
39
Number of buys
13
Number of sells
-10
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Rein Therapeutics, Inc. - Common Stock, $0.001 par value (RNTX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BIOS Fund III, LP 6.2% $6.63M 3.68M BIOS EQUITY PARTNERS III, LP May 5, 2025
Voss Capital, LP 11.3% +95% $3.73M $1.94M 2.67M +109% Voss Capital, LP Sep 24, 2025
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 4.4% $1.58M 961K UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO Nov 4, 2024

Institutional Holders of Rein Therapeutics, Inc. - Common Stock, $0.001 par value (RNTX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 8.49M $9.76M +$2.1M $1.15 39
2025 Q2 6.66M $9.54M +$864K $1.40 35
2025 Q1 6.02M $10.6M +$585K $1.77 37
2024 Q4 5.68M $13.1M -$2.79M $2.30 30
2024 Q3 4.61M $16.3M -$1.01M $3.54 29
2024 Q2 4.89M $13.5M +$5.62M $2.77 27
2024 Q1 1.69M $11M +$3.91M $6.63 22
2023 Q4 1.06M $3.24M +$184K $3.05 19
2023 Q3 1.05M $1.59M +$34.1K $1.52 15
2023 Q2 1.02M $1.83M -$43.1K $1.79 16
2023 Q1 1.05M $1.3M -$652K $1.24 17
2022 Q4 1.36M $3.21M +$3.21M $2.37 16